Research summary
Research HubSelank
Clinical — 10 studies
Selank is a synthetic heptapeptide studied for its anxiolytic and neuroregulatory properties without sedative effects.
Being studied for
- Anxiety-related cognitive research
- Neurotransmitter regulation
- Stress adaptation mechanisms
Published Research
Evidence profile
Controlled human evidence
10 cited publications · 1 primary trial
Findings below belong to the studies that reported them. They describe the material and conditions those authors used, not this product, and not an outcome to expect.
Supporting evidence
[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders]
Medvedev VE et al. · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2014
The study reportedConclusion. The data obtained in the study extend therapeutic possibilities in the treatment of anxiety disorders.
Additional indexed literature (9)
- Preclinical · Mechanistic studySelank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats
Konstantinopolsky MA et al. · Bulletin of experimental biology and medicine · 2022 · PMID 36322304
- Preclinical · Mechanistic studyThe Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress
Leonidovna YA et al. · Current reviews in clinical and experimental pharmacology · 2021 · PMID 32621722
- Preclinical · Mechanistic studyMorphological Changes in the Large Intestine of Rats Subjected to Chronic Restraint Stress and Treated with Selank
Mukhina AY et al. · Bulletin of experimental biology and medicine · 2020 · PMID 32651826
- Preclinical · Mechanistic studyEffect of Selank on Morphological Parameters of Rat Liver in Chronic Foot-Shock Stress
Fomenko EV et al. · Bulletin of experimental biology and medicine · 2019 · PMID 31243679
- Preclinical · Mechanistic studySelank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats
Kolik LG et al. · Bulletin of experimental biology and medicine · 2019 · PMID 31625062
- Preclinical · Mechanistic studyState of Colon Microbiota in Rats during Chronic Restraint Stress and Selank Treatment
Mukhina AY et al. · Bulletin of experimental biology and medicine · 2019 · PMID 31236882
- Preclinical · Mechanistic studyPeptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity
Vyunova TV et al. · Protein and peptide letters · 2018 · PMID 30255741
- Preclinical · Mechanistic studyGABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells
Filatova E et al. · Frontiers in pharmacology · 2017 · PMID 28293190
- Preclinical · Pharmacokinetic study[COMPARISON OF PHARMACOLOGICAL EFFECTS OF HEPTAPEPTIDE SELANK AFTER INTRANASAL AND INTRAPERITONEAL ADMINISTRATION TO BALB/c AND C57BL/6 MICE.]
Vasil'eva EV et al. · Eksperimental'naia i klinicheskaia farmakologiia · 2016 · PMID 29787664
Published studies summarised here concern the specific investigational or pharmaceutical materials and study conditions described by their authors. Their findings are not performance claims for Cobalt Peptides material. Citations verified against PubMed on 2026-08-09.
Notice
All information on this page is provided strictly for laboratory research and educational purposes only.